Hua Wang, Dechun Feng, Ogyi Park, Shi Yin, Bin Gao – 17 May 2013 – Alpha‐Galactosylceramide (α‐Galcer), a specific agonist for invariant natural killer T (iNKT) cells, is being evaluated in clinical trials for the treatment of viral hepatitis and liver cancer. However, the results from α‐Galcer treatment are mixed, partially because of the variety of cytokines produced by activated iNKT cells that have an unknown synergistic effect on the progression of liver disease.

Noémie Péan, Isabelle Doignon, Isabelle Garcin, Aurore Besnard, Boris Julien, Bingkaï Liu, Sophie Branchereau, Anne Spraul, Catherine Guettier, Lydie Humbert, Kristina Schoonjans, Dominique Rainteau, Thierry Tordjmann – 17 May 2013 – Many regulatory pathways are involved in liver regeneration after partial hepatectomy (PH) to initiate growth, protect liver cells, and sustain functions of the remnant liver.

14 May 2013

Daniela P. Ladner, Talia Baker – 25 April 2013

Stuart Kendrick, Chris Day – 24 April 2013 – Watch a video presentation of this article

Stuart Kendrick, Chris Day – 24 April 2013 – Watch a video presentation of this article

Neil D. Theise – 24 April 2013 – Watch a video presentation of this article

D. Alan Herbst, K. Rajender Reddy – 24 April 2013 – Watch a video presentation of this article

Ashwani K. Singal, Bhupinderjit S. Anand – 24 April 2013 – Watch a video presentation of this article

Timothy R. Morgan, Daniel Chao, Gregory Botwin – 24 April 2013 – Watch a video presentation of this article